Insights

Market Expansion Opportunities Fougera Pharmaceuticals, as part of Sandoz and Novartis, is actively launching biosimilars and generic dermatology products across Europe and the US, indicating strong growth momentum and expanding market footprint; potential sales opportunities exist by targeting healthcare providers and networks adopting these new biosimilars and generic medicines.

Product Portfolio Diversification With a diverse product range spanning prescription and OTC dermatologic medicines and recent launches of biosimilars like WYOST and Tyruko, there is a significant opportunity to introduce complementary dermatology treatments and related healthcare solutions to reach broader patient segments.

Technological Enablers Utilization of advanced technology stacks such as SAP, Alteryx, and Elasticsearch suggests a focus on innovation and data-driven decisions, presenting opportunities to develop digital marketing strategies and automated sales tools tailored to healthcare providers and pharmacies.

Partnership and Collaboration Strategic partnerships like the collaboration with LabCorp for diagnostic testing indicate openness to joint ventures in clinical and diagnostic services, offering avenues to co-develop new healthcare solutions or targeted diagnostic products for dermatologic and biosimilar markets.

Customer-Centric Approach Fougera’s focus on high-quality, affordable medicines and recent launches in key markets signal a customer-oriented strategy, creating opportunities to engage healthcare professionals and institutions seeking cost-effective, innovative dermatology and biosimilar treatments.

Similar companies to Fougera Pharmaceuticals Inc.

Fougera Pharmaceuticals Inc. Tech Stack

Fougera Pharmaceuticals Inc. uses 8 technology products and services including Alteryx, SAP, MX Technologies, and more. Explore Fougera Pharmaceuticals Inc.'s tech stack below.

  • Alteryx
    Advanced Analytics And Data Science
  • SAP
    Customer Relationship Management
  • MX Technologies
    Data Security
  • SailPoint
    Identity And Access Management
  • Adobe Captivate
    Miscellaneous
  • Elasticsearch
    Search Engines
  • Webex
    Web Conferencing
  • Twitter
    Widgets

Media & News

Fougera Pharmaceuticals Inc.'s Email Address Formats

Fougera Pharmaceuticals Inc. uses at least 3 format(s):
Fougera Pharmaceuticals Inc. Email FormatsExamplePercentage
First.Last@sandoz.comJohn.Doe@sandoz.com
90%
First.L@sandoz.comJohn.D@sandoz.com
8%
First.Middle@sandoz.comJohn.Michael@sandoz.com
1%
Fir.Last@sandoz.comJoh.Doe@sandoz.com
1%
First.Last@fougera.comJohn.Doe@fougera.com
96%
FirstLast@fougera.comJohnDoe@fougera.com
3%
First.L@fougera.comJohn.D@fougera.com
1%
Last@us.sandoz.comDoe@us.sandoz.com
100%

Frequently Asked Questions

Where is Fougera Pharmaceuticals Inc.'s headquarters located?

Minus sign iconPlus sign icon
Fougera Pharmaceuticals Inc.'s main headquarters is located at 60 Baylis Road Melville, New York 11747 United States. The company has employees across 2 continents, including North AmericaEurope.

What is Fougera Pharmaceuticals Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Fougera Pharmaceuticals Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Fougera Pharmaceuticals Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Fougera Pharmaceuticals Inc.'s official website is us.sandoz.com and has social profiles on LinkedIn.

What is Fougera Pharmaceuticals Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Fougera Pharmaceuticals Inc.'s SIC code is 2834 - Pharmaceutical Preparations NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Fougera Pharmaceuticals Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, Fougera Pharmaceuticals Inc. has approximately 142 employees across 2 continents, including North AmericaEurope. Key team members include Vice President Communications: L. P.Head Of Marketing: R. B.Qc/Ast Head: D. C.. Explore Fougera Pharmaceuticals Inc.'s employee directory with LeadIQ.

What industry does Fougera Pharmaceuticals Inc. belong to?

Minus sign iconPlus sign icon
Fougera Pharmaceuticals Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Fougera Pharmaceuticals Inc. use?

Minus sign iconPlus sign icon
Fougera Pharmaceuticals Inc.'s tech stack includes AlteryxSAPMX TechnologiesSailPointAdobe CaptivateElasticsearchWebexTwitter.

What is Fougera Pharmaceuticals Inc.'s email format?

Minus sign iconPlus sign icon
Fougera Pharmaceuticals Inc.'s email format typically follows the pattern of First.Last@sandoz.com. Find more Fougera Pharmaceuticals Inc. email formats with LeadIQ.

When was Fougera Pharmaceuticals Inc. founded?

Minus sign iconPlus sign icon
Fougera Pharmaceuticals Inc. was founded in 1849.

Fougera Pharmaceuticals Inc.

Pharmaceutical ManufacturingNew York, United States51-200 Employees

Fougera Pharmaceuticals Inc. is focused on specialty pharmaceuticals in dermatology and is a leading manufacturer of prescription and OTC medicines. 
Fougera is a Sandoz company, and part of the Novartis global network.

Fougera has 273 associates working in the development and manufacturing of 65 unique product families and 147 unique SKU’s. Our two facilities are located in Melville and Hicksville, New York. 

The company comprises of two divisions, Fougera - our generic division, and PharmaDerm our branded division, both producing prescription and OTC dermatologic medicines.

Fougera has been serving the pharmaceutical industry for over 170 years, entering the generic market in 1966. With a rich U.S. history of experience and expertise, coupled with its modern technology and innovation, Fougera is poised to lead the way for important new generic introductions. We are steadfast in our mission to discover new ways to improve and extend people’s lives and pioneer novel approaches to help people in the US access high-quality medicine.

In addition to its leading generic business Fougera also has a well-respected branded dermatology business, PharmaDerm. 

PharmaDerm is dedicated to developing and commercializing prescription products to treat diseases and conditions of the skin — the largest organ of the human body. The company has in-house expertise and facilities for formulation development, clinical development, manufacturing, distribution, and sales and marketing. See www.pharmaderm.com for more information.

Section iconCompany Overview

Headquarters
60 Baylis Road Melville, New York 11747 United States
Phone number
SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1849
Employees
51-200

Section iconFunding & Financials

  • $100M$250M

    Fougera Pharmaceuticals Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $100M$250M

    Fougera Pharmaceuticals Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.